SynthesisToxins2021
Evaluation of Mycotoxins in Infant Breast Milk and Infant Food, Reviewing the Literature Data.
Synthesis in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.
- Systematic review and meta-analysis on the prevalence and concentration of aflatoxin BMycotoxin research · 2025Pooled it
- Current status of human biomonitoring of beauvericin and enniatins.Archives of toxicology · 2026Review
- Human biomonitoring of mycotoxins: key challenges and future directions.Mycotoxin research · 2025Review
- Evaluation of safety and health risk characterization of some baby foods in Ghana.Scientific reports · 2025Article
- Assessment of knowledge, attitude and practice of mothers/caregivers on mycotoxin contamination of infants and young children porridge in the Democratic Republic of Congo.Mycotoxin research · 2025Article
- Aflatoxin MToxins · 2025Article
- Article
- Determination of aflatoxin MMycotoxin research · 2024Article
- Occurrence of ochratoxin A in breast milk and urine samples of nursing mothers in Bangladesh.Mycotoxin research · 2024Article
- Longitudinal follow-up of zearalenone and deoxynivalenol mycotoxins in breast milk in the first five months of life.BMC pharmacology & toxicology · 2023Article
- Mycotoxins of Concern in Children and Infant Cereal Food at European Level: Incidence and Bioaccessibility.Toxins · 2022Review
- Article
- Article
- Mycotoxin Exposure during the First 1000 Days of Life and Its Impact on Children's Health: A Clinical Overview.Toxins · 2022Review
- Article
- Kambo: Natural drug or potential toxic agent? A literature review of acute poisoning cases.Toxicology reports · 2022Review
- The Investigation of Mycotoxins and Enterobacteriaceae of Cereal-Based Baby Foods Marketed in Turkey.Foods (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this review, an analysis focusing on mycotoxin determination in infant breast milk and infant food has been summarised for the last fifteen years of research focused on the intended population group of 1-9 months. The objective was to know the level of exposure of the child population to an estimated daily intake (EDI) of mycotoxins from the consumption of habitual foods. The EDI was compared with the tolerable daily intake (TDI) established by EFSA to estimate risk. In breast milk, the high prevalence and levels were for samples from Africa (Egypt and Tanzania) with aflatoxin M1 (1.9 μg/L and 10%), and Asia (Iran) with ochratoxin-A (7.3 μg/L and 100%). In infant formulas, high incidences and values were for samples with aflatoxin M1 from Burkina Faso (167 samples, 84%, 87 μg/kg). In cereal products, the highest incidence was for DON from the United States (96 samples), and the highest value was an Italian sample (0.83 μg/kg of enniatin B). In fruit products, patulin was the most detected in Italian (78) and Spanish (24) samples. The highest risk was observed in breast milk during the first month of age, the highest EDI for aflatoxin M1 was reported for Egypt (344-595 ng/kg bw/day) and ochratoxin-A for Iran (97-167ng/kg bw/day), representing a public health problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.